Forecast & Rating4 analysts currently cover Ironwood Pharma, of which 2 give a positive rating. The average price target is $6.10, about 44.4% upside from the current price of $4.23. Coverage is limited, so the data is for reference only. Data as of Aug 7, 2026; this does not constitute investment advice.
Aug 7, 2026Price forecast
$6.1044.38%
Forecast & RatingBuy
4analysts
- Strong buy25.00%
- Buy25.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met40.7%
Stock price$4.23
Avg. target$6.1
High target$10
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.